EU/3/13/1130

About

On 7 June 2013, orphan designation (EU/3/13/1130) was granted by the European Commission to Westfälische Wilhelms-Universität Münster, Germany, for recombinant human transglutaminase 1 encapsulated into liposomes for the treatment of transglutaminase-1-deficient autosomal recessive congenital ichthyosis.

Key facts

Active substance
Recombinant human transglutaminase 1 encapsulated into liposomes
Disease / condition
Treatment of transglutaminase-1-deficient autosomal recessive congenital ichthyosis
Date of first decision
07/06/2013
Outcome
Positive
EU designation number
EU/3/13/1130

Review of designation

The Committee for Orphan Medicinal Products reviews the orphan designation of a product if it is approved for marketing authorisation.

Sponsor's contact details

Westfälische Wilhelms-Universität Münster
Dezernat 6
Schlossplatz 2
48149 Münster
Germany
Tel. +49 251 8322 151
Fax +49 251 8321 501
E-mail: elke.benkhart@clinic-invent.de

Patients' organisations

For contact details of patients’ organisations whose activities are targeted at rare diseases, see:

  • Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe;
  • European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.

How useful was this page?

Add your rating